Graft-Versus-Host Disease (GVHD) Clinical Trials

A listing of Graft-Versus-Host Disease (GVHD) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Research Center
Duarte California 31010

A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft Versus-Host Disease

View More ▼

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Colorado

Colorado Blood Cancer Institute
Denver Colorado 80218

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Illinois

University of Chicago
Chicago Illinois 60637

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

View More ▼

Chicago Illinois 60637

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Louisiana

Tulane University Medical Center
New Orleans Louisiana 70112

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Beth Israel Deaconess Medical Center
Boston Massachusetts 2215

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Mississippi

University of Mississippi Medical Center
Jackson Mississippi 39216

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

New York

Stony Brook University
Stony Brook New York 11794

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Ohio

Onclology Hematology in Cincinnati
Cincinnati Ohio 45236

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Pennsylvania

UPMC Hillman Cancer Center
Pittsburgh Pennsylvania 15232

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Tennessee

Sarah Cannon Research Institute, LLC
Nashville Tennessee 375203

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Texas

Texas Transplant Institute
San Antonio Texas 78229

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Australia

Parkville Victoria 3002

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Austria

Graz 8036

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Linz A-4010

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Vienna A-1090

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Canada

Hamilton Ontario L8V 5C2

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Czechia

Hradec Kralove CZE 500 05

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Germany

Dresden 01307

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Erlangen 91054

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Leipzig 04103

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Mannheim 68167

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Israel

Haifa 31096

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Petaẖ Tiqwa 49100

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Tel Aviv 64239

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Japan

Nishinomiya Hyogo 663 8501

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Osaka City Osaka 545-8586

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease